Bas van der Baan
2022
In 2022, Bas van der Baan earned a total compensation of $170.4K as Director at LIXTE BIOTECHNOLOGY HOLDINGS.
Compensation breakdown
| Option Awards | $158,525 |
|---|---|
| Other | $11,869 |
| Total | $170,394 |
der Baan received $158.5K in option awards, accounting for 93% of the total pay in 2022.
der Baan also received $11.9K in other compensation.
Rankings
In 2022, Bas van der Baan's compensation ranked 5,454th out of 5,760 executives tracked by ExecPay. In other words, der Baan earned more than 5.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,454 out of 5,760 | 5th |
Division Manufacturing | 2,982 out of 3,136 | 5th |
Major group Chemicals And Allied Products | 1,375 out of 1,422 | 3rd |
Industry group Drugs | 1,283 out of 1,323 | 3rd |
Industry Pharmaceutical Preparations | 936 out of 969 | 3rd |
Source: SEC filing on November 4, 2024.
der Baan's colleagues
We found six more compensation records of executives who worked with Bas van der Baan at LIXTE BIOTECHNOLOGY HOLDINGS in 2022.
2022
René Bernards
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Yun Yen
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Regina Brown
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Stephen Forman
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Philip Palmedo
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Gil Schwartzberg
LIXTE BIOTECHNOLOGY HOLDINGS